Archives of Public Health

Vol. 15 No. 1 (2023): Arch Pub Health
Clinical Science

Correlation of plasma D-dimers with stages of liver cirrhosis and its complications

Online First pdf 52-62
  • Anche Volkanovska,
  • Violeta Dejanova,
  • Vladimir Andreevski,
  • Meri Trajkovska,
  • Danica Labudovikj
Anche Volkanovska
University Clinic for Gastroenterohepatology; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
Violeta Dejanova
Institute for Transfusion Medicine; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
Vladimir Andreevski
University Clinic for Gastroenterohepatology; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
Meri Trajkovska
University Clinic for Gastroenterohepatology; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
Danica Labudovikj
Institute of Medical Biochemistry, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
DOI: https://doi.org/10.3889/aph.2023.6089

Published 2023-06-30

Keywords

  • Model for End-Stage Liver Disease,
  • Child-Pugh-Turcotte,
  • liver cirrhosis,
  • D-dimer,
  • hyperfibrinolysis

How to Cite

1.
Volkanovska A, Dejanova V, Andreevski V, Trajkovska M, Labudovikj D. Correlation of plasma D-dimers with stages of liver cirrhosis and its complications. Arch Pub Health [Internet]. 2023 Jun. 30 [cited 2024 Jul. 16];15(1):52-6. Available from: https://id-press.eu/aph/article/view/6089

Copyright (c) 2023 Anche Volkanovska, Violeta Dejanova, Vladimir Andreevski, Meri Trajkovska, Danica Labudovikj

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Aim of the study: To investigate plasma D-dimer levels in correlation with Child-Pugh-Turcotte (CTP) and Model for End-Stage Liver Disease (MELD) scores in patients with liver cirrhosis (LC) of different severity, as well as the correlation with LC-associated clinical, biochemical parameters and complications. Material and methods: Fifty patients with LC were divided in three groups according to LC severity using the CTP Score (CTP-A, CTP-B, CTP-C).  The levels of D-dimer were measured in sodium-citrate plasma on Siemens, BCS XP Blood Coagulometer. Kruskal-Wallis test was used to compare D-dimer levels between the groups. Mann-Whitney U test was used to evaluate the difference of D-dimer levels in groups with different MELD score, and to evaluate the difference in D-dimer levels in patients with presence or absence of ascites and the difference of D-dimer levels in patients with or without spontaneous bacterial peritonitis (SBP). Pearson’s coefficient of correlation was used to evaluate the correlation between D-dimer levels with MELD score and the correlation between D-dimer levels and the concentration of LC-associated biochemical, clinical parameters and complications. Results: D-dimer levels increased with severity of the disease as assessed with CTP and MELD scores, with a statistically significant difference between the groups (p=.0000 and p=.0001, respectively). Group CTP-C demonstrated the highest D-dimer levels, followed by groups B and A. Patients with SBP had significantly higher levels of D-dimers than patients without SBP (p=.0006). A significant positive correlation between D-dimers and CTP and MELD score was detected (r= 0.74 and r=0.44, respectively; p<.001). A correlation between D-dimer levels and several biochemical parameters characterizing progressive liver dysfunction was observed. From all investigated biochemical parameters, the highest significant correlation was detected between D-dimer levels and the concentration of serum albumin (r= -0.65, p<.001). Conclusions: Plasma D-dimer levels are tightly correlated with the degree of liver dysfunction and LC-associated complications. Therefore, D-dimer levels could be utilized as a prognostic stratification marker and adjunctive diagnostic marker in LC-associated complications. 

Online First pdf 52-62

Downloads

Download data is not yet available.

References

  1. Rodger MA, Le Gal G, Wells P, et al. Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities. Thromb Res 2014;134(4):763-768.https://doi.org/10.1016/j.thromres.2014.07.031 DOI: https://doi.org/10.1016/j.thromres.2014.07.031
  2. Geersing GJ, Janssen KJ, Oudega R, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ. 2009;339:b2990. https://doi.org/10.1136/bmj.b2990 DOI: https://doi.org/10.1136/bmj.b2990
  3. Palareti G, Cosmi B, Legnani C, et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 2014;124(2):196-203.https://doi.org/10.1182/blood-2014-01-548065 DOI: https://doi.org/10.1182/blood-2014-01-548065
  4. Tripodi A. Hemostasis in Acute and Chronic Liver Disease. Semin Liver Dis 2017;37(1):28-32.https://doi.org/10.1055/s-0036-1597770 DOI: https://doi.org/10.1055/s-0036-1597770
  5. Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11(9):1064-1074.https://doi.org/10.1016/j.cgh.2013.02.026 DOI: https://doi.org/10.1016/j.cgh.2013.02.026
  6. Cioni G, Cristani A, Mussini C, et al. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients. Ital J Gastroenterol. 1990;22(2):70-74.
  7. Saray A, Mesihovic R, Gornjakovic S, et al. Association between high D-dimer plasma levels and ascites in patients with liver cirrhosis. Med Arch 2012; 66(6):372-4.https://doi.org/10.5455/medarh.2012.66.372-374 DOI: https://doi.org/10.5455/medarh.2012.66.372-374
  8. El Gohary AM, Elyamany AS, Mikhael NL, Mahmoud MG, Tawfik MMR. Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis. Clin Exp Hepatol. 2021;7(2):134-140.https://doi.org/10.5114/ceh.2021.105915 DOI: https://doi.org/10.5114/ceh.2021.105915
  9. Dai J, Qi X, Li H, Guo X. Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis: A Meta-analysis. Saudi J Gastroenterol. 2015;21(3):165-174. https://doi.org/10.4103/1319-3767.157567 DOI: https://doi.org/10.4103/1319-3767.157567
  10. Li Y, Qi X, Li H, et al. D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study. Exp Ther Med. 2017;13(1):285-289.https://doi.org/10.3892/etm.2016.3930 DOI: https://doi.org/10.3892/etm.2016.3930
  11. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.https://pubmed.ncbi.nlm.nih.gov/4950264/
  12. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124(1):91-96.https://doi.org/10.1053/gast.2003.50016 DOI: https://doi.org/10.1053/gast.2003.50016
  13. El-Sayed R, El-Karaksy H, El-Raziky M, et al. Assessment of coagulation and fibrinolysis in children with chronic liver disease. Blood Coagul Fibrinolysis 2013; 24(2):113-117.https://doi.org/10.1097/MBC.0b013e3283569297 DOI: https://doi.org/10.1097/MBC.0b013e3283569297
  14. Cong YL, Wei YX, Zhang LW, Yin ZJ, Bai J. The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores. Zhonghua Gan Zang Bing Za Zhi. 2005;13(1):31-34. Chinese.https://pubmed.ncbi.nlm.nih.gov/15670488/
  15. Violi F, Ferro D, Basili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995;109(2):531-539.https://doi.org/10.1016/0016-5085(95)90342-9 DOI: https://doi.org/10.1016/0016-5085(95)90342-9
  16. Primignani M, Dell'Era A, Bucciarelli P, et al. High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding. Dig Liver Dis 2008; 40(11):874-881.https://doi.org/10.1016/j.dld.2008.01.010 DOI: https://doi.org/10.1016/j.dld.2008.01.010
  17. Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more. Curr Opin Organ Transplant 2016; 21(2):120-126.https://doi.org/10.1097/MOT.0000000000000281 DOI: https://doi.org/10.1097/MOT.0000000000000281
  18. Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol. 2000;95(11):3218-3224. https://doi.org/10.1111/j.1572-0241.2000.03299.x DOI: https://doi.org/10.1111/j.1572-0241.2000.03299.x
  19. Lisman T, Leebeek FW, Mosnier LO, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001; 121(1):131-139.https://doi.org/10.1053/gast.2001.25481 DOI: https://doi.org/10.1053/gast.2001.25481
  20. Colucci M, Binetti BM, Branca MG, et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 2003; 38(1):230-237.https://doi.org/10.1053/jhep.2003.50277 DOI: https://doi.org/10.1053/jhep.2003.50277
  21. Romanelli R, Cellai A, Lami D, et al. D-dimer and fibrinolytic activity in patients with decompensated liver cirrhosis. Digest Liver Dis 2015; 47: e33. https://doi.org/10.5114/ceh.2021.105915 DOI: https://doi.org/10.1016/j.dld.2015.01.073
  22. Wesam AI, Abdelhakam S, Helmy A, et al. Evaluation of plasma D-dimer level in patients with chronic liver disease. Researcher 2011; 3: 13-18.
  23. Weiyi X, Baode C, Qing X. The application of plasma D-dimer in the diagnosis of spontaneous peritonitis in cirrhotic patients with ascites. Int J Lab Med 2014; 21: 2883-2884.
  24. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.https://doi.org/10.1016/j.jhep.2010.05.004 DOI: https://doi.org/10.1016/j.jhep.2010.05.004
  25. Komolafe O, Roberts D, Freeman SC, et al. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2020;1(1):CD013125.https://doi.org/10.1002/14651858.CD013125.pub2 DOI: https://doi.org/10.1002/14651858.CD013125.pub2

Most read articles by the same author(s)